SER
Price:
$2.1
Market Cap:
$22.75M
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Industry
Biotechnology
IPO Date
2000-01-21
Stock Exchange
AMEX
Ticker
SER
According to Serina Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -402.16%. This represents a change of -119.24% compared to the average of 2.09% of the last 4 quarters.
The mean historical ROE of Serina Therapeutics, Inc. over the last ten years is 4.98%. The current -402.16% ROE has changed -108.08% with respect to the historical average. Over the past ten years (40 quarters), SER's ROE was at its highest in in the December 2025 quarter at 9.02%. The ROE was at its lowest in in the December 2024 quarter at -427.46%.
Average
4.98%
Median
13.14%
Minimum
-1738.07%
Maximum
51.84%
Discovering the peaks and valleys of Serina Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 722.70%
Maximum Annual ROE = 51.84%
Minimum Annual Increase = -3082.81%
Minimum Annual ROE = -1738.07%
| Year | ROE | Change |
|---|---|---|
| 2025 | 51.84% | -3082.81% |
| 2024 | -1738.07% | -1455.75% |
| 2023 | 128.20% | 722.70% |
| 2022 | 15.58% | 45.79% |
| 2021 | 10.69% | -94.97% |
| 2020 | 212.37% | -138.76% |
| 2019 | -547.97% | 443.95% |
| 2018 | -100.74% | 11.46% |
| 2017 | -90.38% | -236.63% |
The current ROE of Serina Therapeutics, Inc. (SER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.74%
5-year avg
10.05%
10-year avg
4.98%
Serina Therapeutics, Inc.’s ROE is greater than Genenta Science S.p.A. (-36.82%), greater than Skye Bioscience, Inc. (-217.27%), less than Jupiter Neurosciences, Inc. (1.14%), greater than Aligos Therapeutics, Inc. (-139.47%), greater than Barinthus Biotherapeutics plc (-63.87%), greater than INmune Bio, Inc. (-170.86%), greater than X4 Pharmaceuticals, Inc. (-94.90%), greater than Telomir Pharmaceuticals, Inc. Common Stock (-201.23%), greater than Grace Therapeutics, Inc. (-14.88%), greater than CEL-SCI Corporation (-221.50%),
| Company | ROE | Market cap |
|---|---|---|
| -36.82% | $32.17M | |
| -217.27% | $24.86M | |
| 1.14% | $8.65M | |
| -139.47% | $32.67M | |
| -63.87% | $27.05M | |
| -170.86% | $38.55M | |
| -94.90% | $398.03M | |
| -201.23% | $48.82M | |
| -14.88% | $36.83M | |
| -221.50% | $7.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Serina Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Serina Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Serina Therapeutics, Inc.'s ROE?
How is the ROE calculated for Serina Therapeutics, Inc. (SER)?
What is the highest ROE for Serina Therapeutics, Inc. (SER)?
What is the 3-year average ROE for Serina Therapeutics, Inc. (SER)?
What is the 5-year average ROE for Serina Therapeutics, Inc. (SER)?
How does the current ROE for Serina Therapeutics, Inc. (SER) compare to its historical average?